Javascript is disabled on your browser
PATIENT Sign In
username:
password:

To obtain a Biolab ID, please contact us at (06) 590 7000
By signing in, you agree to our terms and conditions as well as our
privacy agreement.
(Read more)

Janini - Non-Invasive Prenatal Testing

Get Clear Answers To Your Concerns 

 

Janini is a non-invasive prenatal test that analyzes cell-free fetal DNA obtained from blood of the mother and screens for Down Syndrome (chr.21), Edwards Syndrome (chr.18), Patau Syndrome (chr.13) and Gender of fetus. Janini only requires a blood sample from the mother thus has no risk in any way on both mother and baby's health.

 

 

Janini test can be performed as early as 9 weeks of pregnancy.

 

 

Multiplicom - Belgium, has validated and obtained a CE-IVD marking for its innovative diagnostic product (Clarigo). Biolab has partnered with Multiplicom to offer Janini by clarigo to the region where the samples are sequenced at biolab and the final analysis is jointly generated by biolab and Multiplicom.

 

 

Incidence of trisomy conditions:

 

 

Down Syndrome: 1 in 800 newborns

 

 

Edwards Syndrome: 1 in 6,000 newborns

 

 

Patau Syndrome: 1 in 16,000 newborns

 

 

Janini test limitations:

 

 

Janini test can’t be performed for the following categories -

 

  • ž   Women who are pregnant with twins or multiples
  • ž   Women who are less than 9 weeks pregnant
  • ž   Women with chromosomal abnormalities
  • ž   Women who have undergone one of the following treatments in the last 4 months: blood transfusion, immune therapy, stems cell therapy, transplantation and radiation therapy.

 

Test results are delivered in just 8 working days after the sample is received.



Forgot Password?